140 related articles for article (PubMed ID: 10882699)
1. In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria.
Ackermann G; Schaumann R; Pless B; Claros MC; Rodloff AC
J Antimicrob Chemother; 2000 Jul; 46(1):115-9. PubMed ID: 10882699
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria.
Wexler HM; Molitoris E; Molitoris D; Finegold SM
J Antimicrob Chemother; 2001 Apr; 47(4):467-9. PubMed ID: 11266423
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.
Ackermann G; Schaumann R; Pless B; Claros MC; Goldstein EJ; Rodloff AC
Eur J Clin Microbiol Infect Dis; 2000 Mar; 19(3):228-32. PubMed ID: 10795599
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
Citron DM; Appleman MD
Antimicrob Agents Chemother; 2001 Jan; 45(1):345-8. PubMed ID: 11120995
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of HMR 3647 against anaerobic bacteria.
Edlund C; Sillerström E; Wahlund E; Nord CE
J Chemother; 1998 Aug; 10(4):280-4. PubMed ID: 9720465
[TBL] [Abstract][Full Text] [Related]
6. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
Antimicrob Agents Chemother; 1999 Nov; 43(11):2801-5. PubMed ID: 10543769
[TBL] [Abstract][Full Text] [Related]
7. Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).
Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Sep; 41(9):2019-22. PubMed ID: 9303406
[TBL] [Abstract][Full Text] [Related]
8. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
[TBL] [Abstract][Full Text] [Related]
9. Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole.
Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 May; 41(5):1037-41. PubMed ID: 9145865
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of gemifloxacin (SB 265805) against anaerobes.
Goldstein EJ; Citron DM; Warren Y; Tyrrell K; Merriam CV
Antimicrob Agents Chemother; 1999 Sep; 43(9):2231-5. PubMed ID: 10471570
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrel KL; Fernandez H
Antimicrob Agents Chemother; 2003 Jun; 47(6):1963-7. PubMed ID: 12760875
[TBL] [Abstract][Full Text] [Related]
12. The in vitro activity of trospectomycin against anaerobic bacteria.
Chisari G; Lo Bue AM; Nicoletti G
J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
Wexler HM; Molitoris E; Molitoris D; Finegold SM
Antimicrob Agents Chemother; 1996 Sep; 40(9):2232-5. PubMed ID: 8878617
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.
Boswell FJ; Andrews JM; Ashby JP; Fogarty C; Brenwald NP; Wise R
J Antimicrob Chemother; 1998 Dec; 42(6):703-9. PubMed ID: 10052892
[TBL] [Abstract][Full Text] [Related]
15. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.
Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
Antimicrob Agents Chemother; 1998 May; 42(5):1127-32. PubMed ID: 9593139
[TBL] [Abstract][Full Text] [Related]
16. The effect of carbon dioxide on the in vitro activity of erythromycin and RU-28965 against anaerobic bacteria.
Felmingham D; Robbins MJ; Marais R; Ridgway GL; Gruneberg RN
Drugs Exp Clin Res; 1987; 13(4):195-9. PubMed ID: 3113907
[TBL] [Abstract][Full Text] [Related]
17. Comparative activity of SCH 34343 against anaerobic bacteria.
Sutter VL; Wexler H; Finegold SM
Diagn Microbiol Infect Dis; 1986 Apr; 4(4):341-4. PubMed ID: 3698546
[TBL] [Abstract][Full Text] [Related]
18. Activity of cefotetan against anaerobic bacteria.
Dias MB; Jacobus NV; Tally FP; Gorbach SL
Diagn Microbiol Infect Dis; 1986 Apr; 4(4):359-63. PubMed ID: 3457672
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria.
Phillips OA; Rotimi VO; Jamal WY; Shahin M; Verghese TL
J Chemother; 2003 Apr; 15(2):113-7. PubMed ID: 12797385
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of Bay Y3118 against anaerobic bacteria.
Wexler HM; Molitoris E; Finegold SM
Antimicrob Agents Chemother; 1993 Nov; 37(11):2509-13. PubMed ID: 8285647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
